SCHEMBL6521877

SCHEMBL6521877

CC(=O)CCCCCCCCCO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAOX Q6QHF9 5/20 0.59
▸ GPR84 Q9NQS5 1/20 0.57
▸ FFAR1 O14842 1/20 0.57
▸ FFAR4 Q5NUL3 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.50
▸ ACHE P22303 1/20 0.46
▸ LMNA P02545 4/20 0.43
▸ TSHR P16473 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ FNTA P49354 1/20 0.43
▸ FNTB P49356 1/20 0.43
▸ SLC15A2 Q16348 1/20 0.41
▸ CAMK2A Q9UQM7 1/20 0.41
▸ GAA P10253 1/20 0.39
▸ NFKB1 P19838 1/20 0.38
▸ PMP22 Q01453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26376399 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL148759 1.00 — —
SCHEMBL14917740 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL5200218 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL169164 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL5784769 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL10865193 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL4793246 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL2525609 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E
SCHEMBL3950984 1.00 PAOX (0.59) PAOXGPR84FFAR1FFAR4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139079-A1 METHOD FOR PRODUCING PURIFIED POLYTETRAFLUOROETHYLENE AQUEOUS DISPERSION LIQUID, METHOD FOR PRODUCING MODIFIED POLYTETRAFLUOROETHYLENE POWDER, METHOD FOR PRODUCING POLYTETRAFLUOROETHYLENE MOLDED BODY, AND COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2026-05-21 — — US disclosed
US-12540203-B2 Method for producing purified polytetrafluoroethylene aqueous dispersion liquid, method for producing modified polytetrafluoroethylene powder, method for producing polytetrafluoroethylene molded body, and composition DAIKIN INDUSTRIES, LTD. (JP) 2026-02-03 — — US disclosed
EP-4657572-A1 COMPOSITION, ELECTROCHEMICAL DEVICE BINDER, ELECTRODE MIXTURE, ELECTRODE, AND SECONDARY BATTERY Daikin Industries, Ltd. (JP) 2025-12-03 — — EP disclosed
US-20250361380-A1 PRODUCTION METHOD FOR FLUOROPOLYMER, SURFACTANT FOR POLYMERIZATION, AND USE OF SURFACTANT DAIKIN IND LTD (JP) 2025-11-27 — — US disclosed
US-20250349886-A1 TETRAFLUOROETHYLENE-BASED POLYMER COMPOSITION, SOLID-STATE SECONDARY BATTERY BINDER, ELECTROLYTE LAYER MIXTURE, ELECTRODE MIXTURE, ELECTRODE, AND SOLID-STATE SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-11-13 — — US disclosed
US-20250349857-A1 SELF-SUPPORTING ELECTROCHEMICAL DEVICE MIXTURE FILM, ELECTRODE, AND ELECTROCHEMICAL DEVICE DAIKIN INDUSTRIES, LTD. (JP) 2025-11-13 — — US disclosed
US-20250346697-A1 POLYTETRAFLUOROETHYLENE COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2025-11-13 — — US disclosed
US-20250349858-A1 ELECTROCHEMICAL DEVICE MIXTURE, ELECTROCHEMICAL DEVICE MIXTURE SHEET, ELECTRODE, AND ELECTROCHEMICAL DEVICE DAIKIN INDUSTRIES, LTD. (JP) 2025-11-13 — — US disclosed
US-20250349859-A1 TETRAFLUOROETHYLENE-BASED POLYMER COMPOSITION, ELECTROCHEMICAL DEVICE BINDER, ELECTRODE MIXTURE, ELECTRODE, AND SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-11-13 — — US disclosed
US-12404387-B2 Production method for fluoropolymer, surfactant for polymerization, and use of surfactant DAIKIN INDUSTRIES, LTD. (JP) 2025-09-02 — — US disclosed
EP-3498686-A1 HYDROCARBON-CONTAINING CARBOXYLIC ACID, HYDROCARBON-CONTAINING SULFONIC ACID, HYDROCARBON-CONTAINING SULFURIC ACID ESTER OR SALT THEREOF, AND SURFACTANT Daikin Industries, Ltd. (JP) 2019-06-19 — — EP disclosed
US-8263774-B2 Quinoline-oxazoline compounds and their use in oxidation synthesis UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2012-09-11 — — US disclosed
US-20110054176-A1 QUINOLINE-OXAZOLINE COMPOUNDS AND THEIR USE IN OXIDATION SYNTHESIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-03 — — US disclosed
US-20080312135-A1 MIXTURES OF DRUG-OLIGOMER CONJUGATES COMPRISING POLYETHYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME EKWURIBE NNOCHIRI N 2008-12-18 — — US disclosed
US-6255276-B1 MUSK MACROMOLECULE GIVAUDEN ROURE (INTERNATIONAL) S.A. (CH) 2001-07-03 — — US disclosed
EP-0908455-A1 Macrocycles GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1999-04-14 — — EP disclosed
US-4618724-A Perfluorocarbon polymer oxidation catalyst and preparation of carbonyl compound E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-10-21 — — US disclosed
US-4617153-A PERFLUOROCARBON POLYMER CONTAINING DIFLUOROMETHYLENE CHROMIUM SULFONYL PENDANT GROUPS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-10-14 — — US disclosed
US-4455441-A ALPHA-FLUORO-OMEGA HYDROXY STRAIGHT CHAIN HYDROCARBONS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1984-06-19 — — US disclosed
EP-0104880-A2 Attractant termiticidal compounds, compositions and methods of use therefor THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1984-04-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540203-B2 Method for producing purified polytetrafluoroethylene aqueous dispersion liquid, method for producing modified polytetrafluoroethylene powder, method for producing polytetrafluoroethylene molded body, and composition PHOSPHO1, RER1, PF4 PAOX 202/4885GPR84 3902/4885FFAR1 1128/4885
US-20110054176-A1 QUINOLINE-OXAZOLINE COMPOUNDS AND THEIR USE IN OXIDATION SYNTHESIS XDH, OXA1L, AOX1 PAOX 119/4885GPR84 2494/4885FFAR1 3885/4885
US-20260139079-A1 METHOD FOR PRODUCING PURIFIED POLYTETRAFLUOROETHYLENE AQUEOUS DISPERSION LIQUID, METHOD FOR PRODUCING MODIFIED POLYTETRAFLUOROETHYLENE POWDER, METHOD FOR PRODUCING POLYTETRAFLUOROETHYLENE MOLDED BODY, AND COMPOSITION TAF5, PF4, TAF9 PAOX 937/4885GPR84 4191/4885FFAR1 2020/4885
US-20080312135-A1 MIXTURES OF DRUG-OLIGOMER CONJUGATES COMPRISING POLYETHYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME SI, SLC10A2, FABP2 PAOX 529/4885GPR84 1515/4885FFAR1 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback